OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following companies are approved for trading on the OTCQB® Venture Market:
Delcath Systems, Inc. (OTCQB: DCTH) Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. Delcath’s proprietary product-Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)-is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. The Company's principal focus is on the treatment of primary and metastatic liver cancers. In the United States, the Melphalan/HDS system is considered a combination drug and device product, and is regulated as a drug by the United States Food and Drug Administration (FDA). The Melphalan/HDS system has not been approved for sale in the United States. In Europe, it’s proprietary system to deliver and filter melphalan hydrochloride is marketed as a device under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT). In April 2012, the company obtained authorization to affix a CE Mark for the Generation Two CHEMOSAT system. The right to affix the CE mark allows the Company to market and sell the CHEMOSAT system in Europe. The Company has commenced a global phase 2 clinical trial in Europe to investigate Melphalan/HDS system for primary liver cancer and is initiating plans to evaluate intrahepatic cholangiocarcinoma.
Maricann Group Inc. (CSE: MARI; OTCQB: MRRCF) Founded in 2013 in Langton, Ontario, Maricann Group Inc. is a publicly traded medical cannabis company that serves thousands of patients. Maricann Group Inc is currently expanding its cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada, and ultimately into mature and developing cannabis markets worldwide. With dedication to quality, integrity, authenticity, approachability and innovation, Maricann strives to exceed expectations and industry standards.
PreveCeutical Medical Inc. (CSE: PREV; OTCQB: PRVCF) PreveCeutical Medical Inc. is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products.
Tower One Wireless Corp. (CSE: TO; OTCQB: TOWTF) Tower One Wireless Corp., a Canadian company, focuses on owning and operating wireless telecom infrastructure sites in South American markets that are experiencing strong growth. Its primary focus is property selection, architecture and engineering, and zoning acquisition of wireless infrastructure, including towers. Its core business is providing access to its infrastructure to (FOR) major national and multi-national cellular carriers through long-term leases (10 plus years). With the migration to fourth generation (4G) long-term evolution (LTE) networks in Colombia and Argentina, there will be strong demand for additional towers, with growth expected be over 1,000/towers a year in each country.
U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for these companies on www.otcmarkets.com.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.